CARISMA Therapeutics Stock (NASDAQ: CARM) stock price, news, charts, stock research, profile.
You can purchase shares of CARISMA Therapeutics (NASDAQ:CARM) through any online brokerage.
Other companies in CARISMA Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Acurx Pharmaceuticals (NASDAQ:ACXP), Coeptis Therapeutics (NASDAQ:COEP), Evaxion Biotech (NASDAQ:EVAX) and Nanoviricides (AMEX:NNVC).
CARISMA Therapeutics has a consensus price target of $9.54.
The stock price for CARISMA Therapeutics (NASDAQ: CARM) is $0.4309 last updated January 17, 2025 at 5:42 PM EST.
There are no upcoming dividends for CARISMA Therapeutics.
CARISMA Therapeutics’s Q4 earnings are confirmed for Monday, March 31, 2025.
There is no upcoming split for CARISMA Therapeutics.
CARISMA Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.